clade-wise differences requires head-tohead comparisons (clade 1 vs clade 2, etc), which were not conducted.
Although not compared statistically, Figure 1C suggests that any increased mortality among clade 2 cases versus clades 1 or 3 was limited to patients ≥75 years old [2] . Frailty and comorbidities pose significant risks for death in older adults [1, 3] . Therefore, efforts to quantify clade-specific effects on mortality need to control for these factors. It is notable that data in the authors' Figure 4 revealed lower serum sodium levels among clade 2 [2] . Because hyponatremia is associated with a number of chronic diseases [4] and is independently associated with mortality [5, 6] , this lab abnormality might have been an indicator of comorbidity imbalance among clade 2-infected patients.
Studies relating pathogen genotype with clinical outcome are challenging when different genetic lineages infect distinct patient populations [7] . Although clade 2 strains are more prevalent in older adults and older adults are more likely to die from CDI, it remains unproven whether these 2 observations are causally related. Strain typing remains an important tool for epidemiology, but the role of such methods in guiding treatment remains absent [8] . Future studies that attribute significant differences in patient mortality to different C. difficile genotypes should adjust for patient age and underlying comorbidities, and should identify a genotype-specific virulence factor. Whole genome sequencing may help unmask currently unknown microbial determinants of disease severity that can be leveraged to improve CDI prevention and therapy. 
Notes

